Barriers to metabolic care for adults with serious mental illness: Provider perspectives

International Journal of Psychiatry in Medicine

Volumn 41, Issue 4, 2011, Pages 379-387

  McDonell, Michael ^a   Kaufman, Erin ^a   Srebnik, Debra ^a   Ciechanowski, Paul ^a   Ries, Richard ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

barriers to care; metabolic syndrome; primary care; primary care provider; serious mental illness

Indexed keywords

ARTICLE; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HEALTH SERVICE; HUMAN; MENTAL DISEASE; MENTAL HEALTH; METABOLIC REGULATION; NORMAL HUMAN; PRIMARY MEDICAL CARE; PUBLIC HEALTH SERVICE; RESOURCE MANAGEMENT;

ADULT; ANTIPSYCHOTIC AGENTS; COMMUNITY MENTAL HEALTH CENTERS; COMORBIDITY; DATA COLLECTION; DIABETES MELLITUS, TYPE 2; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HUMANS; MASS SCREENING; METABOLIC SYNDROME X; PATIENT CARE TEAM; PHYSICIAN'S ROLE; PRIMARY HEALTH CARE; PSYCHOTIC DISORDERS;

EID: 80155197738     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.41.4.g     Document Type: Article

References (19)

1. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease 2006;3(2):A42.
2. NASMHPD. Morbidity and mortality in people with serious mental illness. Parks JJ, Svendsen D, Singer P, Foti M, editors. National Association of State Mental Health Program Directors Medical Directors Council, 2006.
3. American Psychiatric Association. Consensus development conference on antipsychotic drugs and obesity and diabetes. Journal of Clinical Psychiatry 2004;65(2): 267-272.
4. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. American Heart Journal 2005;150(6):1115-1121. (Pubitemid 41773510)
5. Newcomer JW. Metabolic considerations in the use of antipsychotic medications: A review of recent evidence. Journal of Clinical Psychiatry 2007;68(Suppl 1):20-27.
6. Meyer JM, Stahl SM. The metabolic syndrome and schizophrenia. Acta Psychiatrica Scandinavica 2009;119(1):4-14.
7. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, et al. Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry 2004;161(8):1334-1349. (Pubitemid 38989085)
8. Morrato EH, Nicol GE, Maahs D, Druss BG, Hartung DM, Valuck RJ, et al. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Archives of General Psychiatry 2010;67(1):17-24.
9. Morrato EH, Cuffel B, Newcomer JW, Lombardo I, Kamat S, Barron J. Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes. Diabetes Care 2009;32(6):1037-1042.
10. Bell RC, Farmer S, Ries R, Srebnik D. Metabolic risk factors among Medicaid outpatients with schizophrenia receiving second-generation antipsychotics. Psychiatric Services 2009;60(12):1686-1689.
11. Druss BG, Marcus SC, Campbell J, Cuffel B, Harnett J, Ingoglia C, et al. Medical services for clients in community mental health centers: Results from a national survey. Psychiatric Services 2008;59(8):917-920.
12. Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research 2006;86(1-3):15-22. (Pubitemid 44234064)
13. Druss BG. Improving medical care for persons with serious mental illness: Challenges and solutions. Journal of Clinical Psychiatry 2007;68(Suppl 4):40-44. (Pubitemid 46762122)
14. Druss BG, Rosenheck RA. Mental disorders and access to medical care in the United States. American Journal of Psychiatry 1998;155(12):1775-1777. (Pubitemid 28547507)
15. Levinson Miller C, Druss BG, Dombrowski EA, Rosenheck RA. Barriers to primary medical care among patients at a community mental health center. Psychiatric Services 2003; 54(8):1158-1160. (Pubitemid 36951519)
16. DHHS. Substance abuse treatment for persons with co-occurring disorders. A treatment improvement protocol TIP 42. Rockville MD: US DHHS, 2005.
17. Katon WJ. Collaborative care: Evidence-based models that improve primary care depressive outcomes. CNS Spectrums 2009;14(Suppl 12):10-13.
18. Druss BG, von Esenwein SA, Compton MT, Rask KJ, Zhao L, Parker RM. A randomized trial of medical care management for community mental health settings: The Primary Care Access, Referral, and Evaluation (PCARE) study. American Journal of Psychiatry 2010; 167(2):151-159.
19. Ries RK, Dyck DG, Short R, Srebnik D, Fisher A, Comtois KA. Outcomes of managing disability benefits among patients with substance dependence and severe mental illness. Psychiatric Services 2004;55(4):445-447. (Pubitemid 38445595)